125 related articles for article (PubMed ID: 15632952)
1. Antiopioid properties of the TYR-MIF-1 family.
Bocheva A; Dzambazova-Maximova E
Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
[TBL] [Abstract][Full Text] [Related]
2. Effects of Tyr-MIF's family of peptides on immobilization stress-induced antinociception in rats.
Bocheva AI; Dzambazova-Maximova EB
Folia Med (Plovdiv); 2004; 46(2):42-6. PubMed ID: 15506550
[TBL] [Abstract][Full Text] [Related]
3. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
4. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
[TBL] [Abstract][Full Text] [Related]
5. Effect of diphenylhydramine on the Tyr-MIF-1 antinociception in rats.
Bocheva A; Zamfirova R; Pajpanova T; Todorov S; Georgieva M; Golovinsky E
Arch Physiol Biochem; 1998 Dec; 106(5):378-83. PubMed ID: 10441059
[TBL] [Abstract][Full Text] [Related]
6. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
[TBL] [Abstract][Full Text] [Related]
7. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
9. Tyr-W-MIF-1-induced conditioned place preference.
Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
[TBL] [Abstract][Full Text] [Related]
12. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
Harrison LM; Zadina JE; Banks WA; Kastin AJ
Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
[TBL] [Abstract][Full Text] [Related]
13. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
[TBL] [Abstract][Full Text] [Related]
14. MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis.
Kavaliers M
Peptides; 1987; 8(1):1-5. PubMed ID: 2883631
[TBL] [Abstract][Full Text] [Related]
15. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
Zadina JE; Kastin AJ; Hackler L; Chang SL
Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
[TBL] [Abstract][Full Text] [Related]
16. Effects of Tyr-MIF-1 on stress-induced analgesia and the blockade of development of morphine tolerance by stress in mice.
Fukunaga H; Takahashi M; Kaneto H; Yoshikawa M
Jpn J Pharmacol; 1999 Feb; 79(2):231-5. PubMed ID: 10202859
[TBL] [Abstract][Full Text] [Related]
17. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
18. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
Galina ZH; Kastin AJ
Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
[TBL] [Abstract][Full Text] [Related]
19. Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception.
Kastin AJ; Stephens E; Zadina JE; Coy DH; Fischman AJ
Pharmacol Biochem Behav; 1985 Dec; 23(6):1045-9. PubMed ID: 2867563
[TBL] [Abstract][Full Text] [Related]
20. Effect of Tyr-MIF-1 peptides on blood ACTH and corticosterone concentration induced by three experimental models of stress.
Bocheva A; Dzambazova E; Hadjiolova R; Traikov L; Mincheva R; Bivolarski I
Auton Autacoid Pharmacol; 2008 Oct; 28(4):117-23. PubMed ID: 18798907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]